CFN Media Group interviews CURE Pharmaceutical's (OTCQB: CURR) executive team: Robert Davidson, CEO and Chairman; Wayne Nasby, COO; and Jessica Rousset, CBO. CURE Pharmaceutical is a fully integrated specialty bioscience company with proprietary dosage forms and delivery systems, the CureFilm™ platform. CureFilm™ can be applied to a broad range of molecules to improve drug efficacy, safety and the patient experience. CURE was founded with the goal of changing the way in which quality medicines are delivered to people in need, regardless of geography or economic status. The company operates on the principle of social purpose by extending its focus beyond products and services to maximize its impact on the world. With this founding principle, the company founded Oak Therapeutics, a subsidiary of CURE focused on bringing life-saving medicines to developing economies.